1. Introduction {#sec1}
===============

Nontyphoidal *Salmonella* infection is a common cause for acute bacterial gastroenteritis in children in China \[[@B1], [@B2]\]. The main symptoms of nontyphoidal *Salmonella* gastroenteritis in infants and children include acute onset of diarrhea, vomiting, fever, abdominal pain, and irritability. Nontyphoidal *Salmonella* gastroenteritis is mostly a self-limiting disease and resolves within one week in healthy children \[[@B3]\]. However, disease course may be prolonged in children with secondary lactase deficiency or food allergies \[[@B4]--[@B6]\]. There has been no study to assess the prevalence of lactose intolerance or food allergies in children with nontyphoidal *Salmonella* gastroenteritis. The aim of this study was to characterize nontyphoidal *Salmonella* gastroenteritis in a tertiary children\'s hospital in southern China and evaluate clinical presentation, lactose intolerance, and food allergies in children with prolonged nontyphoidal *Salmonella* gastroenteritis.

2. Methods {#sec2}
==========

A retrospective case-series analysis was carried out in a tertiary children\'s hospital in Guangzhou, China. We reviewed all cases with stool culture performed and included all infants and children who were diagnosed with nontyphoidal *Salmonella* gastroenteritis between 1 January 2014 and 31 December 2016. Patients\' clinical features, feeding patterns, laboratory tests, and treatment outcomes were reviewed. All children underwent routine evaluation including a complete blood count, electrolytes, C-reactive protein (CRP), blood culture for bacteria and fungus, stool culture for bacteria (*Escherichia coli*, *Salmonella, Shigella*, *Campylobacter*, and *Enterobacter aerogenes*), and stool viral antigen tests (rotavirus and adenovirus). All laboratory works were performed at our hospital laboratory, which is a standard tertiary hospital facility. The diagnosis of nontyphoidal *Salmonella* gastroenteritis was confirmed by stool culture. *Salmonella* isolates from stool samples were serotyped per standard protocol.

Treatments of children with nontyphoidal *Salmonella* gastroenteritis include general supportive care and antibiotic therapy if indicated \[[@B3]\]. Choices of antibiotics were guided by local antimicrobial resistance pattern and/or antimicrobial susceptibility testing. For patients with diarrhea that lasted for ≥7 days, stools were tested for carbohydrate malabsorption, and a lactose-free diet or formula was initiated if the stool reducing substance was positive and stool pH was \<5.5 \[[@B7]\]. For children with confirmed or clinically suspected food allergies, hypoallergenic formula/diet would be initiated.

The institutional ethics committee of Guangzhou Women and Children\'s Medical Center approved this study protocol.

3. Results {#sec3}
==========

There were 7379 stool cultures performed between 1 January 2014 and 31 December 2016. As shown in [Table 1](#tab1){ref-type="table"}, a total of 142 infants and children were diagnosed with nontyphoidal *Salmonella* gastroenteritis, with male predominance. About half (52.1%) of them presented at \<12 months of age. All infants presented with diarrhea 2--30 times/day with average 8 times/day. Most patients had mucus and blood in stools. Other common presenting symptoms included fever, vomiting, abdominal pain, bloating/distention, and irritability. Laboratory tests showed that most patients (89.4%) had elevated CRP. Leukocytosis, thrombocytosis, and anemia occurred in 42.3%, 40.8%, and 36.6% of children, respectively. Microscopic stool exam showed increased WBC and RBC in 62.7% and 33.1% of patients, respectively. Stool occult blood was positive in the majority (78.2%) of children.

Stool culture was positive for nontyphoidal *Salmonella* in all children. *Salmonella* Typhimurium was the predominant serotype, accounting for 82.4% of isolates. Other minor serotypes included Enteritidis, Saintpaul, Bovis mortificans, Thompson, Paratyphi B, and A.

Twenty-six children had prior infections including 20 (14.1%) with respiratory infection and 6 (4.2%) with hand, foot, and mouth disease.

All patients received supportive care including oral rehydration, probiotics (*Lactobacillus*/*Bifidobacterium* and/or *Saccharomyces boulardii*), and montmorillonite. 91.5% of patients were treated with antibiotics, with 73.2% administered intravenously. Forty-one (28.9%) children improved with lactose-free formula and/or diet when diarrhea persisted for more than a week and stool testing was positive for carbohydrate malabsorption. Five patients were tested positive for serum allergen-specific IgE (sIgE), and 4 patients were highly suspected of food allergy based on clinical symptoms although sIgE was negative. All 9 patients (6.3%) improved with hypoallergenic formula (extensively hydrolyzed or amino-acid formula).

All children had clinical resolution with majority (90.8%) within 2 weeks. No significant adverse reactions were observed.

4. Discussion {#sec4}
=============

Nontyphoidal *Salmonella* is a major enteric pathogen for acute bacterial gastroenteritis in children in China \[[@B1], [@B8], [@B9]\]. In our study, about half of cases occurred in infants ≤ 12 months of age and the majority (89.4%) in children younger than 3 years old, consistent with other reports \[[@B1], [@B2]\]. The main symptoms in our cohort were diarrhea, fever, and vomiting. Most infants and children had mucus and/or blood in stools. Laboratory study revealed that the majority (89.4%) of patients had elevated CRP while leukocytosis, thrombocytosis, and anemia occurred in less than 50% of cases.

In our study, nontyphoidal *Salmonella* Typhimurium was the predominant (82.4%) serotype, followed distantly by Enteritidis (8.5%), Saintpaul (4.2%), bovis morbificans (1.4%), Thompson (1.4%), Paratyphi B (1.4%), and Paratyphi A (0.7%). Our results were different from those reported by others in China. Ran et al. reported that serotype Enteritidis (31%) and serotype Typhimurium (26%) were the most common, and Li et al. found that Enteritidis (38.9%) and Typhimurium (29.7%) were the most common serotypes \[[@B1], [@B9]\]. The inconsistency may be due to the changing epidemiological trend, the regional variation, and the specific patient population. As a tertiary children\'s center, the patients in this study were referred from surrounding hospitals due to persistent symptoms in spite of supportive care and other treatments. It would be interesting to investigate the nontyphoidal *Salmonella* serotype in those surrounding hospitals.

Antibiotic therapy is generally not recommended for uncomplicated gastroenteritis in healthy children with nontyphoidal *Salmonella* infection \[[@B3]\]. In our study, the majority (91.5%) of infants and children received oral or intravenous antibiotics. This is likely due to our specific patient population referred from surrounding hospitals where initial supportive care failed. With appropriate antibiotic therapy and other supportive care, the majority (90.8%) of our patients had clinic resolution within 2 weeks.

Early studies suggest that secondary lactose intolerance and food allergies occur in children with acute infectious diarrhea, and lactose-free or hypoallergenic formulas improve symptoms \[[@B4], [@B5], [@B10]\]. However, there has been no any reports of the prevalence of lactose intolerance or food allergies in children with nontyphoidal *Salmonella* infection. Our study showed that 28.9% of children had significant symptom improvement with a lactose-free formula or diet, indicating that secondary lactase deficiency occurs frequently in children with nontyphoidal *Salmonella* gastroenteritis. Only 6.3% had confirmed or suspected food allergies. Dietary modification should be considered when diarrhea is persistent and prolonged.

The major strength of this study is that this is the first report of relatively common secondary lactase deficiency in children with nontyphoidal *Salmonella* gastroenteritis. However, this study has weaknesses and limitations. This is a retrospective case review, and a standard lactose breath test was not used to diagnose lactose intolerance. A larger epidemiology study would be necessary to assess the true prevalence of lactose intolerance and food allergies in children with nontyphoidal *Salmonella* infection.

5. Conclusions {#sec5}
==============

This study demonstrates that *Salmonella* Typhimurium was the predominant serotype. Most patients with nontyphoidal *Salmonella* gastroenteritis are younger than 3 years old, and the main symptoms are diarrhea, fever, and vomiting. Lactose intolerance occurs frequently in children with nontyphoidal *Salmonella* gastroenteritis. Dietary modification should be considered when diarrhea is persistent and prolonged.
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Basic characteristics, clinical features, and laboratory tests and treatments in 142 infants and children with nontyphoidal *Salmonella* gastroenteritis.

  ------------------------------------- -------------
  Age                                   
   \<12 months                          74 (52.1%)
   1--3 years                           53 (37.3%)
  ≥3 years                              15 (10.6%)
  Sex, M/F                              64.1%/35.9%
  Disease duration at presentation      
   \<2 weeks                            100 (70.4%)
   2--4 weeks                           31 (21.8%)
   ≥4 weeks                             11 (7.8%)
  Prior illness                         
   Respiratory infection                20 (14.1%)
   Hand, foot, and mouth disease        6 (4.2%)
  Symptoms                              
   Diarrhea                             142 (100%)
    Mucus in stool                      85 (59.9%)
    Blood in stool                      76 (53.5%)
   Fever (T ≥ 38°C)                     88 (62.0%)
   Nausea and vomiting                  26 (18.3%)
   Bloating/distention                  10 (7.0%)
   Abdominal pain                       10 (7.0%)
   Irritability                         5 (3.5%)
  Laboratory studies                    
   Leukocytosis (≥12 × 10^9^/L)         60 (42.3%)
   Thrombocytosis (≥300 × 10^9^/L)      58 (40.8%)
   Anemia (HB\< 110 g/L)                52 (36.6%)
   CRP (≥1 mg/L)                        127 (89.4%)
   Stool WBC ≥ (++)                     89 (62.7%)
   Stool RBC ≥ (++)                     47 (33.1%)
   Stool occult blood (+)               111 (78.2%
  Stool culture: positive Salmonella    142 (100%)
   Salmonella serotype                  
    Typhimurium                         117 (82.4%)
    Enteritidis                         12 (8.5%)
    Saintpaul                           6 (4.2%)
    bovis morbificans                   2 (1.4%)
    Thompson                            2 (1.4%)
    Paratyphi B                         2 (1.4%)
    Paratyphi A                         1 (0.7%)
  Treatments                            
   Antibiotics                          130 (91.5%)
    Oral antibiotics                    26 (18.3%)
    IV antibiotics                      104 (73.2%)
   Lactose-free formula/diet            41 (28.9%)
   Hypoallergenic formula               9 (6.3%)
  Clinical resolution after treatment   
   \<2 weeks                            129 (90.8%)
   2--4 weeks                           9 (6.3%)
   \>4 weeks                            4 (2.8%)
  ------------------------------------- -------------
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